+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
GalNAc & GalNAc Derivatives Market by Application (Diagnostics, Pharmaceuticals, Research), Product Type (GalNAc, GalNAc Conjugates), End User, Technology, Distribution Channel - Global Forecast 2025-2030- Product Image
GalNAc & GalNAc Derivatives Market by Application (Diagnostics, Pharmaceuticals, Research), Product Type (GalNAc, GalNAc Conjugates), End User, Technology, Distribution Channel - Global Forecast 2025-2030- Product Image
New

GalNAc & GalNAc Derivatives Market by Application (Diagnostics, Pharmaceuticals, Research), Product Type (GalNAc, GalNAc Conjugates), End User, Technology, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6123238
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
As glycosylation science advances, the role of N-acetylgalactosamine and its structural derivatives has become a cornerstone of targeted therapeutic modalities. These carbohydrate moieties enable selective delivery of oligonucleotide drugs to hepatocytes through receptor-mediated endocytosis, dramatically improving the pharmacokinetic profile of next-generation treatments. Moreover, the expanding repertoire of GalNAc conjugates offers a versatile platform for both diagnostics and therapeutic applications, opening new frontiers in precision medicine.

With research activity accelerating in academic and industrial settings alike, the integration of GalNAc chemistry into drug delivery systems has transitioned from concept to clinic in record time. Breakthroughs in synthetic methodologies and analytical validation have paved the way for scalable manufacturing processes, while strategic collaborations between biotechnology innovators and contract research organizations have fueled an unprecedented pace of development. Consequently, stakeholders across the value chain are now capitalizing on these technologies to address a broad range of hepatic and metabolic diseases.

Unveiling Pivotal Transformations Shaping the Global GalNAc and Derivatives Landscape Across Research and Therapeutic Applications

The landscape of GalNAc and derivative innovation has undergone profound transformations driven by converging scientific breakthroughs and evolving market dynamics. Over recent years, enzymatic and solid-phase synthetic techniques have matured, offering enhanced purity, yield, and structural diversity. This has facilitated the design of multi-valent conjugates that exhibit superior receptor engagement and reduced off-target effects. In parallel, liquid-phase methodologies have gained traction for their cost-efficiency, enabling larger-scale production without compromising the sophisticated architecture required for therapeutic efficacy.

Regulatory frameworks have also adapted to the unique considerations of oligonucleotide therapeutics, streamlining approval pathways for GalNAc-based drug candidates. Collaboration between regulatory agencies, academic research centers, and industry partners has fostered harmonized guidelines, accelerating time to market. As a result, there is a noticeable shift away from conventional small molecules toward biologically inspired glycan conjugates. This collective momentum is redefining how stakeholders perceive carbohydrate-based platforms and is reshaping strategic priorities across R&D portfolios.

Assessing the Far-Reaching Consequences of 2025 United States Tariff Policies on the GalNAc and Derivative Supply Chain Dynamics

Anticipated tariff adjustments in 2025 are poised to exert significant pressure on global supply chains for GalNAc materials and related intermediates. Increased duties on imported inputs could drive raw material costs upward, compelling manufacturers to reassess sourcing strategies and potentially accelerate onshore production initiatives. These shifts may also incentivize vertical integration among leading producers as they seek to mitigate exposure to trade policy volatility.

Simultaneously, research organizations and contract analytics providers may encounter tighter budgetary constraints, prompting prioritization of high-value projects over exploratory studies. In response, alliances between domestic and international entities are likely to intensify, as stakeholders work collaboratively to maintain cost efficiencies while preserving access to critical reagents. Over time, these adaptations will influence pricing structures, procurement timelines, and project feasibility assessments, underscoring the need for agile supply chain management and proactive risk mitigation.

Delving into Multifaceted Segmentation Dimensions to Unlock Comprehensive Market Intelligence for GalNAc and Related Derivatives

In examining the multifaceted segmentation of the GalNAc ecosystem, application areas reveal both depth and diversity. Within diagnostics, GalNAc derivatives enhance biomarker specificity, while the pharmaceutical domain leverages drug delivery systems and oligonucleotide therapeutics to achieve targeted gene silencing. Research applications span academic investigations that explore glycan-receptor biology to industrial initiatives focused on scalable production and process optimization. This breadth of application underscores the adaptability of GalNAc platforms across distinct scientific and commercial settings.

Product type differentiation further highlights market specialization. Native GalNAc serves as a versatile building block for receptor-targeted conjugates, whereas GalNAc conjugates incorporate defined linkers and payloads for bespoke therapeutic design. This evolution from simple monosaccharides to advanced conjugates reflects growing sophistication in chemoselective synthesis and molecular engineering.

End users play a pivotal role in driving demand and innovation. Biotechnology companies spearhead early-stage discovery, while contract research organizations accelerate translational workflows. Pharmaceutical companies then advance candidates through clinical development, and research institutes contribute foundational knowledge and precompetitive data sharing. Together, these entities form an interconnected value chain that fosters rapid iteration and iterative improvement.

Technological enablers, ranging from enzymatic synthesis that offers regioselective control to liquid-phase techniques that balance throughput and cost, and solid-phase methods optimized for purity, are integral to production scalability. Each approach delivers distinct advantages, enabling tailored manufacturing strategies that align with project scale and complexity. Distribution channels complete the picture: while direct sales ensure close customer collaboration and technical support, distributors extend geographic reach, and e-commerce platforms facilitate efficient ordering for smaller laboratories. Collectively, these segmentation dimensions illuminate the intricate pathways through which GalNAc innovations traverse from concept to end user.

Global Regional Dynamics Revealing Strategic Growth Opportunities for GalNAc and Derivative Markets Across Major Economic Territories

Regional dynamics reveal a tapestry of opportunity and challenge for GalNAc development. In the Americas, strong research funding, robust biotech clusters, and supportive regulatory frameworks have fostered an environment ripe for early-stage discovery and clinical translation. This region remains a hotbed for strategic partnerships that integrate academic innovation with commercial execution, driving a pipeline of GalNAc-based therapies toward regulatory milestones.

Across Europe, the Middle East, and Africa, governmental initiatives and public-private alliances are enhancing capabilities in both academic and industrial research. Collaborative networks spanning multiple countries enable knowledge exchange on manufacturing best practices and regulatory alignment, while emerging markets in the Middle East invest in biotechnology infrastructure to diversify their economic base. These developments offer pathways for GalNAc suppliers to form new alliances and capitalize on evolving demand.

In the Asia-Pacific, rapid industrialization, significant investments in life science research, and growing domestic pharmaceutical sectors are redefining the competitive landscape. Countries in this region are investing heavily in advanced synthesis platforms and analytical technologies, enabling local production of high-purity GalNAc derivatives. Market participants can leverage these capabilities to build resilient supply chains and tap into a burgeoning pool of research talent.

Profiling Leading Industry Players and Strategic Collaborations Driving Innovation in the GalNAc and Derivative Marketplace

Leading industry players are forging novel pathways through strategic collaborations and proprietary technology platforms. Biotechnology pioneers are aligning with contract research organizations to accelerate target validation and streamline process development for GalNAc conjugates. At the same time, specialty chemical manufacturers are enhancing their operational capabilities through acquisitions and capacity expansions, ensuring consistent supply of high-quality materials.

Some companies are differentiating through investments in enzyme engineering, enabling chemoenzymatic pathways that reduce reaction steps and minimize downstream purification challenges. Others are expanding patent portfolios around linker chemistries and conjugation techniques that optimize payload release profiles. Meanwhile, alliances between pharmaceutical sponsors and academic centers are generating valuable clinical data, de-risking late-stage development programs. These varied approaches illustrate how leadership in this space is defined not only by technological prowess but also by the ability to integrate across functions and geographies.

Implementing Targeted Strategic Roadmaps to Enhance Competitive Advantages and Foster Sustainable Growth in the GalNAc Derivative Ecosystem

Industry leaders should adopt a multi-pronged strategy to strengthen market position and drive sustainable growth. Prioritizing investment in enzyme-based synthesis will yield long-term benefits in cost efficiency and product consistency, while parallel development of solid-phase methodologies can address niche applications requiring the highest purity standards. Collaborative ventures that bring together academic expertise with commercial scale-up capabilities will unlock synergies and accelerate time to market.

Moreover, cultivating robust relationships with regional distributors and local research institutes can diversify distribution networks and reduce reliance on single suppliers. Engaging proactively with regulatory authorities to shape guidance around oligonucleotide therapeutics will create predictable pathways for approval, reducing cycle times and lowering compliance risk. Finally, continuous portfolio evaluation-guided by rigorous return-on-innovation metrics-will ensure that resource allocation aligns with both scientific promise and commercial viability.

Employing Rigorous Mixed-Methods Research Frameworks to Ensure Robust Analysis and Credible Insights in GalNAc Market Studies

The foundation of this analysis rests on a robust mixed-methods framework designed to capture both breadth and depth of market dynamics. Primary insights were gathered through in-depth interviews with senior executives, technology leaders, and procurement specialists spanning biotechnology companies, contract research organizations, and academic institutions. These qualitative perspectives were complemented by a comprehensive review of secondary sources, including patent filings, clinical trial registries, and peer-reviewed publications.

Quantitative validation was achieved via proprietary data sets and triangulation of multiple public databases to ensure consistency and reliability. This dual-layered approach was further reinforced by a series of expert workshops convened to vet preliminary findings and calibrate key assumptions. Where applicable, regional analyses were cross-checked with localized industry reports and regulatory filings, ensuring that the insights reflect the most current environment. By employing this rigorous methodology, the resulting intelligence offers a balanced, transparent, and actionable foundation for strategic decision-making.

Consolidating Core Learnings to Chart a Forward-Looking Vision for GalNAc Derivatives in an Evolving Biotechnological Ecosystem

The evolution of GalNAc and its derivatives underscores a broader shift toward precision-targeted therapies and advanced biomanufacturing paradigms. Strategic investments in synthesis technologies, coupled with dynamic stakeholder collaborations, have propelled this field from foundational research into clinical reality. Navigating emerging trade policies, regional variations, and competitive moves requires an agile mindset underpinned by solid intelligence.

By integrating segmentation insights, regional analyses, and company profiles, industry participants can make informed choices about R&D prioritization, supply chain resilience, and partnership models. Looking ahead, those who harness the full potential of GalNAc conjugation platforms will shape the next wave of therapeutic innovation, setting new benchmarks for efficacy, safety, and patient outcomes.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Application
    • Diagnostics
    • Pharmaceuticals
      • Drug Delivery Systems
      • Oligonucleotide Therapeutics
    • Research
      • Academic Research
      • Industrial Research
  • Product Type
    • GalNAc
    • GalNAc Conjugates
  • End User
    • Biotechnology Companies
    • Contract Research Organizations
    • Pharmaceutical Companies
    • Research Institutes
  • Technology
    • Enzymatic Synthesis
    • Liquid-Phase Synthesis
    • Solid-Phase Synthesis
  • Distribution Channel
    • Direct Sales
    • Distributors
    • E-Commerce Platforms
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Avantor, Inc.
  • Tokyo Chemical Industry Co., Ltd.
  • Bachem Holding AG
  • Azenta, Inc.
  • Danaher Corporation
  • Evonik Industries AG
  • FUJIFILM Holdings Corporation
  • Sumitomo Chemical Company, Limited

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of GalNAc conjugates in targeted RNA therapies for rare genetic disorders
5.2. Expansion of subcutaneous delivery platforms leveraging GalNAc derivatives for enhanced hepatic targeting
5.3. Development of dual-functional GalNAc-siRNA conjugates for improved potency and reduced off-target effects
5.4. Strategic partnerships between biotech firms and CROs to accelerate GalNAc-based oligonucleotide pipeline development
5.5. Regulatory approvals for novel GalNAc-conjugated therapeutics catalyzing investment in hepatic gene silencing technologies
5.6. Advances in linker chemistry optimizing stability and release kinetics of GalNAc conjugated biomolecules for improved efficacy
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. GalNAc & GalNAc Derivatives Market, by Application
8.1. Introduction
8.2. Diagnostics
8.3. Pharmaceuticals
8.3.1. Drug Delivery Systems
8.3.2. Oligonucleotide Therapeutics
8.4. Research
8.4.1. Academic Research
8.4.2. Industrial Research
9. GalNAc & GalNAc Derivatives Market, by Product Type
9.1. Introduction
9.2. GalNAc
9.3. GalNAc Conjugates
10. GalNAc & GalNAc Derivatives Market, by End User
10.1. Introduction
10.2. Biotechnology Companies
10.3. Contract Research Organizations
10.4. Pharmaceutical Companies
10.5. Research Institutes
11. GalNAc & GalNAc Derivatives Market, by Technology
11.1. Introduction
11.2. Enzymatic Synthesis
11.3. Liquid-Phase Synthesis
11.4. Solid-Phase Synthesis
12. GalNAc & GalNAc Derivatives Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.4. E-Commerce Platforms
13. Americas GalNAc & GalNAc Derivatives Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa GalNAc & GalNAc Derivatives Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific GalNAc & GalNAc Derivatives Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Thermo Fisher Scientific, Inc.
16.3.2. Merck KGaA
16.3.3. Avantor, Inc.
16.3.4. Tokyo Chemical Industry Co., Ltd.
16.3.5. Bachem Holding AG
16.3.6. Azenta, Inc.
16.3.7. Danaher Corporation
16.3.8. Evonik Industries AG
16.3.9. FUJIFILM Holdings Corporation
16.3.10. Sumitomo Chemical Company, Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. GALNAC & GALNAC DERIVATIVES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. GALNAC & GALNAC DERIVATIVES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. GALNAC & GALNAC DERIVATIVES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. GALNAC & GALNAC DERIVATIVES MARKET: RESEARCHAI
FIGURE 26. GALNAC & GALNAC DERIVATIVES MARKET: RESEARCHSTATISTICS
FIGURE 27. GALNAC & GALNAC DERIVATIVES MARKET: RESEARCHCONTACTS
FIGURE 28. GALNAC & GALNAC DERIVATIVES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. GALNAC & GALNAC DERIVATIVES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DRUG DELIVERY SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY OLIGONUCLEOTIDE THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY OLIGONUCLEOTIDE THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY ACADEMIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY INDUSTRIAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY INDUSTRIAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY GALNAC, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY GALNAC, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY GALNAC CONJUGATES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY GALNAC CONJUGATES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY ENZYMATIC SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY ENZYMATIC SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY LIQUID-PHASE SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY LIQUID-PHASE SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY SOLID-PHASE SYNTHESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 93. CANADA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 94. CANADA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 95. CANADA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 96. CANADA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 97. CANADA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 98. CANADA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 99. CANADA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 100. CANADA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 101. CANADA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. CANADA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. CANADA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 104. CANADA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 105. CANADA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 106. CANADA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 107. MEXICO GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 108. MEXICO GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 109. MEXICO GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 110. MEXICO GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 111. MEXICO GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 112. MEXICO GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 113. MEXICO GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 114. MEXICO GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 115. MEXICO GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. MEXICO GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. MEXICO GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 118. MEXICO GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 119. MEXICO GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. MEXICO GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. GERMANY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. GERMANY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. GERMANY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 182. GERMANY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 183. GERMANY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 184. GERMANY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 185. GERMANY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. GERMANY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. GERMANY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. GERMANY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. GERMANY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 190. GERMANY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 191. GERMANY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 192. GERMANY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 193. FRANCE GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. FRANCE GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. FRANCE GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 196. FRANCE GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 197. FRANCE GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 198. FRANCE GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 199. FRANCE GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 200. FRANCE GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 201. FRANCE GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. FRANCE GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. FRANCE GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 204. FRANCE GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 205. FRANCE GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. FRANCE GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. ITALY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 222. ITALY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 223. ITALY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 224. ITALY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 225. ITALY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 226. ITALY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 227. ITALY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. ITALY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. ITALY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. ITALY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. ITALY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 232. ITALY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 233. ITALY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. ITALY GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. SPAIN GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. SPAIN GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. SPAIN GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 238. SPAIN GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 239. SPAIN GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 240. SPAIN GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 241. SPAIN GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 242. SPAIN GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 243. SPAIN GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. SPAIN GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. SPAIN GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. SPAIN GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. SPAIN GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. SPAIN GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. DENMARK GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 292. DENMARK GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 293. DENMARK GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 294. DENMARK GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 295. DENMARK GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 296. DENMARK GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 297. DENMARK GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 298. DENMARK GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 299. DENMARK GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. DENMARK GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. DENMARK GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 302. DENMARK GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 303. DENMARK GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. DENMARK GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS GALNAC & GALNAC DERIVATIVES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS GALNAC & G

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this GalNAc & GalNAc Derivatives market report include:
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Avantor, Inc.
  • Tokyo Chemical Industry Co., Ltd.
  • Bachem Holding AG
  • Azenta, Inc.
  • Danaher Corporation
  • Evonik Industries AG
  • FUJIFILM Holdings Corporation
  • Sumitomo Chemical Company, Limited

Related Topics

Related Reports

D Alpha Parahydroxy Phenylglycine & Derivatives Market by Application (Agrochemicals, Cosmetics, Food and Beverage), Derivative Type (Amides, Esters, Salts), Product Form, Purity Grade, Distribution Channel - Global Forecast 2025-2030 - Product Image

D Alpha Parahydroxy Phenylglycine & Derivatives Market by Application (Agrochemicals, Cosmetics, Food and Beverage), Derivative Type (Amides, Esters, Salts), Product Form, Purity Grade, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Androstenedione & Derivatives Market by Application (Cosmetics, Dietary Supplements, Pharmaceutical), Product Type (Anhydrous, Monohydrate), Derivative, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Androstenedione & Derivatives Market by Application (Cosmetics, Dietary Supplements, Pharmaceutical), Product Type (Anhydrous, Monohydrate), Derivative, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Game IP Derivatives Market by Types (Apparel & Accessories, Sequal Video Games, Stationery), Platform (Console Games, Cross-Platform Games, Mobile Games), Genre - Global Forecast 2025-2030 - Product Image

Game IP Derivatives Market by Types (Apparel & Accessories, Sequal Video Games, Stationery), Platform (Console Games, Cross-Platform Games, Mobile Games), Genre - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Aldehydes Market by Product Type (Benzaldehyde, Formaldehyde, Isobutyraldehyde), Application (Chemical Intermediates, Fragrances & Flavors, Pharmaceuticals), End Use Industry, Derivative, Purity Grade - Global Forecast 2025-2030 - Product Image

Aldehydes Market by Product Type (Benzaldehyde, Formaldehyde, Isobutyraldehyde), Application (Chemical Intermediates, Fragrances & Flavors, Pharmaceuticals), End Use Industry, Derivative, Purity Grade - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Oxetane Derivatives Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application - Product Image

Oxetane Derivatives Global Market Insights 2025, Analysis and Forecast to 2030, by Manufacturers, Regions, Technology, Application

  • Report
  • 75 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.